Drug Shortage Report for PROCYTOX
Report ID | 217583 |
Drug Identification Number | 02241800 |
Brand name | PROCYTOX |
Common or Proper name | Cyclophosphamide for injection, 2G powdered vial |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | CYCLOPHOSPHAMIDE |
Strength(s) | 2000MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 2000 mg (20 mg/mL) (2638B5035) |
ATC code | L01AA |
ATC description | ALKYLATINGAGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-01-29 |
Actual start date | 2024-01-29 |
Estimated end date | 2024-03-15 |
Actual end date | 2024-02-27 |
Shortage status | Resolved |
Updated date | 2024-02-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-02-28 | English | Compare |
v5 | 2024-02-27 | French | Compare |
v4 | 2024-02-27 | English | Compare |
v3 | 2024-01-30 | English | Compare |
v2 | 2024-01-29 | French | Compare |
v1 | 2024-01-29 | English | Compare |
Showing 1 to 6 of 6